Skip to main content
Figure 2 | BMC Nephrology

Figure 2

From: N-acetylcysteine does not prevent contrast nephropathy in patients with renal impairment undergoing emergency CT: a randomized study

Figure 2

Median and dispersion of the evolution of creatinine and cystatin C after CT. (a) Median and dispersion of the evolution of creatinine at day 0, day 2, day 4 and day 10 after CT in the N-acetylcysteine group (white) and in the control group (grey); (b) Median and dispersion of the evolution of cystatin C at day 0, day 2, day 4 and day 10 after CT in the N-acetylcysteine group (white) and in the control group (grey).

Back to article page